Biosimilar trastuzumab on the PBS - information for health professionals and patients

A new biosimilar brand of trastuzumab (Kanjinti^®) has listed on the PBS on 1 December 2019. Information about this listing for health professionals and patients can be found on the Biosimilar Awareness Initiative web page.